RPS6KB2
Basic information
Region (hg38): 11:67428460-67435401
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (78 variants)
- not_provided (3 variants)
- RPS6KB2-related_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RPS6KB2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003952.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 79 | 79 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 79 | 1 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RPS6KB2 | protein_coding | protein_coding | ENST00000312629 | 15 | 6942 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 5.96e-21 | 0.000431 | 124631 | 0 | 213 | 124844 | 0.000853 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.205 | 316 | 306 | 1.03 | 0.0000197 | 3090 |
| Missense in Polyphen | 128 | 112.41 | 1.1387 | 1196 | ||
| Synonymous | -1.67 | 147 | 123 | 1.19 | 0.00000777 | 981 |
| Loss of Function | -0.618 | 29 | 25.6 | 1.13 | 0.00000127 | 287 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00110 | 0.00108 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00230 | 0.00228 |
| Finnish | 0.0000466 | 0.0000464 |
| European (Non-Finnish) | 0.000884 | 0.000874 |
| Middle Eastern | 0.00230 | 0.00228 |
| South Asian | 0.00128 | 0.00128 |
| Other | 0.000330 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphorylates specifically ribosomal protein S6.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Fc gamma R-mediated phagocytosis - Homo sapiens (human);TGF-beta signaling pathway - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Insulin resistance - Homo sapiens (human);HIF-1 signaling pathway - Homo sapiens (human);Longevity regulating pathway - multiple species - Homo sapiens (human);Acute myeloid leukemia - Homo sapiens (human);Breast cancer - Homo sapiens (human);ErbB signaling pathway - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Longevity regulating pathway - Homo sapiens (human);Apelin signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Colorectal cancer - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);IL-5 Signaling Pathway;AMP-activated Protein Kinase (AMPK) Signaling;Follicle Stimulating Hormone (FSH) signaling pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Cytoplasmic Ribosomal Proteins;Insulin Signaling;IL-2 Signaling Pathway;Disease;Signal Transduction;AKT phosphorylates targets in the nucleus;IL-7 signaling;PIP3 activates AKT signaling;JAK STAT pathway and regulation;EPO signaling;Constitutive Signaling by AKT1 E17K in Cancer;PI3K/AKT Signaling in Cancer;VEGF;Intracellular signaling by second messengers;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.286
Intolerance Scores
- loftool
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 32.15
Haploinsufficiency Scores
- pHI
- 0.240
- hipred
- Y
- hipred_score
- 0.512
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.905
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Rps6kb2
- Phenotype
- neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- translation;protein phosphorylation;signal transduction;intracellular signal transduction;protein kinase B signaling;positive regulation of translational initiation
- Cellular component
- nucleus;nucleoplasm;cytoplasm
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;ribosomal protein S6 kinase activity;ATP binding;peptide binding